The convenience and lower cost of the oral pill may be critical to some patients, which could expand the market, improve ...

When it comes to cost, the Wegovy pill is expected to be a $25 or less copay per month if covered by insurance. Without ...

Novo Nordisk’s Wegovy weight loss pill hit U.S. pharmacies this week. Here’s how it works, who qualifies, how to take it, ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...

In Canada, the patent for some semaglutide drugs has expired, paving the way for the country to become the first to offer ...

People turning to injectable GLP-1 treatments—a class of drugs that mimics that hormone to control diabetes and promote weight loss—now have another way to take the medication. On Dec. 22, the U.S.

A pill version of the GLP-1 weight-loss drug Wegovy is expected to debut in the U.S. in early January. But how will the pills stack up against the already widely used injectables? Doctors in Western ...

Danish drugmaker Novo Nordisk said the first-of-its kind oral pill will offer 1.5 and 4 milligram doses at $149 per month for ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. For years, GLP-1 medications like Novo ...

The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...